Background-Cardiovascular disease and type 2 diabetes mellitus represent overlapping diseases where a large portion of the variation attributable to genetics remains unexplained. An important player in their pathogenesis is peroxisome proliferator-activated receptor γ (PPARγ) that is involved in lipid and glucose metabolism and maintenance of metabolic homeostasis. We used a functional genomics methodology to interrogate human chromatin immunoprecipitationsequencing, genome-wide association studies, and expression quantitative trait locus data to inform selection of candidate functional single nucleotide polymorphisms (SNPs) falling in PPARγ motifs. Methods and Results-We derived 27 328 chromatin immunoprecipitation-sequencing peaks for PPARγ in human adipocytes through meta-analysis of 3 data sets. The PPARγ consensus motif showed greatest enrichment and mapped to 8637 peaks. We identified 146 SNPs in these motifs. This number was significantly less than would be expected by chance, and Inference of Natural Selection from Interspersed Genomically coHerent elemenTs analysis indicated that these motifs are under weak negative selection. A screen of these SNPs against genome-wide association studies for cardiometabolic traits revealed significant enrichment with 16 SNPs. A screen against the MuTHER expression quantitative trait locus data revealed 8 of these were significantly associated with altered gene expression in human adipose, more than would be expected by chance. Several SNPs fall close, or are linked by expression quantitative trait locus to lipid-metabolism loci including CYP26A1. Conclusions-We demonstrated the use of functional genomics to identify SNPs of potential function. Specifically, that SNPs within PPARγ motifs that bind PPARγ in adipocytes are significantly associated with cardiometabolic disease and with the regulation of transcription in adipose. This method may be used to uncover functional SNPs that do not reach significance thresholds in the agnostic approach of genome-wide association studies. (Circ Cardiovasc Genet. 2015;8:842-851.
C ardiovascular disease and type 2 diabetes mellitus represent overlapping complex diseases to which both genetic and environmental factors contribute. Despite hundreds of genome-wide hits from genome-wide association studies (GWAS), a large portion of the variation in cardiometabolic traits attributable to genetic factors remains unexplained. 1 Because of stringent statistical cutoffs necessary in the GWAS methodology, it is argued many common variants with an appreciable effect on phenotypic variation are reported as false negatives and dismissed. 2, 3 For example, a study by Visscher 4 demonstrated that ≈50% of human height variability can be explained by the simultaneous analysis of >1 million single nucleotide polymorphisms (SNPs), compared with the 16% collectively explained by GWAS.
Clinical Perspective on p 851
In recent years, a wealth of Big Data repositories and published results from Consortia studies have been released to the scientific community. [5] [6] [7] [8] [9] [10] [11] [12] Furthermore, a considerable number of post-GWAS studies have demonstrated the use of integrating multiple data sets to functionally annotate GWAS hits. 13, 14 More recently, investigators have been implementing functional genomics approaches to inform the selection of SNPs for candidate association studies and functional experiments, thus avoiding the multiple comparison burden of GWAS. For example, Xu et al 15 recently used a candidate pathway-based functional genomics approach to identify 2 putative functional SNPs related to cardiovascular disease in Chinese cohorts that would not have reach significance by GWAS thresholds.
Here, we have applied a functional genomics approach to characterize common human variation in predicted peroxisome proliferator response elements (PPREs) derived from experimentally determined chromatin immunoprecipitationsequencing (ChIP-Seq) peaks for PPARγ. PPARγ controls the expression of gene networks involved in adipogenesis, lipid metabolism, insulin sensitivity, and maintenance of overall metabolic homeostasis. 16 Synthetic compounds acting as agonists of PPARγ are routinely prescribed for individuals with diabetes mellitus and dyslipidemia. Furthermore, there is evidence that dietary poly-and mono-unsaturated fatty acids, as well as modified fatty acids, act as agonists for PPARγ in vivo. 17 Indeed, functional variants exist within the PPARγ locus, which associate with cardiometabolic traits. 18 It would stand to reason that SNPs falling in PPREs would be candidates for functional investigation, however, their pursuit has been complicated by various factors. For one, not all identified PPARγ consensus motifs are functionally relevant. Also, known PPARγ-binding sites often lie within gene desert regions. 19, 20 This previous knowledge of PPARγ has led us to hypothesize that SNPs falling within PPARγ motifs will have functional consequence detectable in cardiometabolic association and expression data. To investigate this, we have first taken advantage of relevant Big Data and derived 27 328 consensus ChIP-Seq peaks for PPARγ in human adipocytes through meta-analysis of 3 published data sets. We subsequently identified the direct repeat 1 (DR1) PPARγ consensus motif as the most highly enriched motif subsequently found, with high confidence, in 8637 peaks. For these sequences, we showed an overall low degree of conservation across mammals while demonstrating a fraction is under weak negative selection in humans. In the second part of our study, we identified 146 common SNPs in these PPARγ sequences and discovered 16 are enriched for significance in published GWAS results for cardiometabolic traits. We found 8 of these 16 SNPs show a significant enrichment for expression quantitative trait locus (eQTL) effects in data from human adipose.
We have demonstrated how a previous knowledge candidate SNP hypothesis can be investigated using publicly available data to identify SNPs of potential function. Moreover, by investigating a subset of SNPs, with putative functional mechanisms, we lessen the burden of multiple comparisons that limit the effectiveness of the agnostic GWAS approach. The methods described here may be used to interrogate GWAS data for SNPs of functional significance.
Methods

GWAS Association Data
GWAS data for anthropometric traits of body mass index and waist circumference, adjusted for age, sex, and study specific variables, in ≤339 224 subjects of European ancestry from a meta-analysis of 125 studies were obtained from the Genetic Investigation of ANthropometric Traits (GIANT) consortium. 10, 11 Meta-analyzed GWAS data for fasting insulin and glucose, from ≤58 074 subjects of European ancestry were obtained from published results from the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC). The statistical model adjusted for age, sex, body mass index, and study-specific variables, whereas subjects on diabetes mellitus medications or diagnosed with type 2 diabetes mellitus were excluded. 12 Meta-analyzed GWAS data for lipid-related traits of high-density lipoprotein, low-density lipoprotein, and triglycerides, from ≤188 577 subjects of European ancestry were obtained from published results from the Global Lipids consortium. The statistical model adjusted for age, sex, and study-specific variables while subjects on lipid-lowering medications were excluded. 9 A perl script was written to collect association data for each PPARγ SNP from each study. All GWAS data sets used here included unfiltered association results for all SNPs tested.
To identify candidate PPARγ SNPs of potential functional relevance, we chose SNPs based on a nominal significance threshold of P<0.01 to reduce false negatives.
ChIP-Seq Data Sets and Processing
Raw immunoprecipitated ChIP and control input data for PPARγ in mature human adipose cells was retrieved from 3 studies from the Gene Expression Omnibus and European Nucleotide Archive databases. 7, 21 Reads for the 3 studies used were processed through a quality control pipeline. First, ≤8 bases on the 5′ end of each read with low-quality base pair calling were trimmed and primer sequence artifacts removed with trimmomatic. 22 Trimmomatic was then used to remove any read with a phred score of <10 across its length.
Reads that passed quality control were aligned to the human genome (hg19) using Bowtie (settings, -n 2 -m 1 -y -a -best -strata). 23 Unique aligned reads were used to call peaks using the standard protocol for the Model-based Analysis of ChIP-Seq (MACS) software. 24 To control for potential bias of tag count differences with MACS, the same number of mapped tags for ChIP and control input were used. 24
Meta-Analysis of ChIP-Seq Data Sets
Meta-analysis of ChIP-Seq data was performed with performed with the Model-based Meta-analysis of ChIP data (MM-ChIP) software. 25 Briefly, MM-ChIP uses a sliding window approach to detect enriched regions of the pooled read input. First, the MACS algorithm was used to model the characteristic fragment size (d) of the ChIP-DNA library for each data set. MACS shifted each tag toward the 3′ direction by half the distance of d to better model the precise binding regions of the data set. The modelshifted tags from all the 3 data sets were pooled and analyzed with the MM-ChIP software using the estimated d for each study above. A false discovery rate threshold of q<0.05 was used for a significance threshold.
Motif Enrichment Analysis
Multiple Em for Motif Elicitation (MEME)-ChIP was used to identify the most enriched transcription factor motifs in the MM-ChIP peak data. MEME-ChIP is a software suite that performs multiple analyses on a set of DNA sequences. 26 Sequences used consisted of 300 bases centered on the summit reported by MM-ChIP for each peak.
To determine the significance of the enriched motifs, we used the fasta-get-markov script to generate a third-order background model from a 25-kb sequence ending 5-kb upstream of each input peak. This file was used in our analysis to control for background noise with the -bfile option.
We submitted the top 1000 MM-ChIP peak sequences (ranked by P value) to MEME-ChIP to discover enriched and novel de novo motifs. MEME-ChIP then matched significant de novo motifs to known transcription factor binding site by searching against the Jaspar Core vertebrate motif database and the PPRE identified by Lemay et al, 27 using the TomTom algorithm. 28 MEME-ChIP further identified the most centrally enriched motifs across the input sequences using the Centrimo algorithm.
Comparison of PPARγ Motif Across Studies
To compare the enrichment of the PPARγ motif across MM-ChIP and 3 input data sets, the PERL Ensembl variation API tools were used to obtain a 100 base sequence centered around the summit of each peak for each data set, ranked by P value. 29 These data sets were processed through the transcription factor motif-finding tool FIMO. We implemented a standard q value cutoff of <0.05. We created a background file for each study, with the same settings as above, which was implemented in this analysis with the -bfile option. 30
Screening PPARγ Motifs for SNPs
A perl script was written to map the motif coordinates provided by FIMO against dbSNP 141. We excluded all non biallelic SNPs or noncommon SNPs with a minor allele frequency of <0.10, resulting in 146 unique SNPs.
Sequence Conservation and Selection Analysis
The average vertebrate 46-way phastcons conservation scores of the 8637 PPRE elements identified in this study were determined with the completeMOTIFS webtool. 31 A phastcons score of ≥0.57 corresponding to conservation across mammals was used as a conservation threshold. 32 To generate the background conservation estimate, we randomly generated 100 sets of 8637 15 nt sequences. The phastcons scores for each of the 8637 sequences in each set were retrieved from completeMOTIFS. Each of the 100 sets were sorted, by ascending phastcons score, and an average score calculated for each of the 8637 sequences.
To assess the likelihood of observing 146 SNPs in 8637 15 nt sequences, we generated 1000 random sets of 8637 15 nt sequences from across hg19. The probability of observing 146 common SNPs from the genome was determined based on the normal distribution generated from the 1000 simulations. To determine if selection was occurring in the 8637 PPARγ motif sequences, we used the Inference of Natural Selection from Interspersed Genomically coHerent elemenTs (INSIGHT) webtool. 33 An allele frequency threshold of 10% and a minimum neutral flanking site threshold of 100 were used. INSIGHT integrates information on natural selection by contrasting patterns of polymorphism and divergence in transcription factor-binding sites with those in neutral flanking regions, thus alleviating biases from demography, variation in mutation rate, and differences in coalescence time. 33 Information about polymorphism was obtained by using genome data of human subjects from Complete Genomics and divergence information from multiple primate outgroup genomes using a general statistical phylogenetic approach. An Expectation-maximization algorithm was used by INSIGHT to produce maximum likelihood estimates of the model parameters describing the effect of the fraction of sites under selection (ρ), the number of divergences driven by positive (Dp) selection, and the number of polymorphisms under weak negative selection (Pw). Expected values for Dp and Pw were obtained by summing over site-wise posterior probabilities. To allow comparisons between sets of different sizes, INSIGHT normalized E(Dp) and E(Pw) by dividing them by the total number of nucleotide sites considered (in kilobases). A likelihood ratio test was used to evaluate evidence for selection in general, positive selection, and weak negative selection. A more thorough description of INSIGHT methods has been described previously. 33 
eQTL Analysis
For each PPARγ SNP, all SNP-gene raw eQTL P values from 860 human subcutaneous adipose tissue samples were downloaded from the MuTHER website. 8 A perl script was used to screen our 16 PPARγ SNPs against the eQTL data. To correct for multiple testing P values were adjusted with the R Q-Value package. 34 
SNP Enrichment in GWAS and eQTL
To determine if PPARγ SNPs were enriched for significant association with cardiometabolic traits, we submitted our 124 SNPs to the SNPSNAP webportal using the settings r 2 distance cutoff of 0.80, minor allele frequency±5%, Gene Density to ±50%, distance to nearest gene ±50%, and linkage disequilibrium (LD) buddies ±50% resulting in 1000 matched data sets. 35 The probability of observing 16 significant SNPs from GWAS was determined based on the normal distribution generated from the number of SNPs from each matched set having a P<0.01. Similarly, for eQTL SNPs we used SNPSNAP with same the settings to generate 1000 matched sets of 16 SNPs. Each set was screened through the eQTL data and a normal distribution was generated from the number of eQTLs having a q value of <0.20.
Linkage Disequilibrium
Phase 3 data CEU genotype data were downloaded from 1000 Genomes ftp site. 6 Haploview was used to determine SNPs in LD with the 146 PPARγ SNPs using an r 2 threshold of ≥0.90 and ≥0.80. 36
Motif Annotation With Genomic Regions Enrichment of Annotations Tool
To investigate potential pathways enriched by the 8637 PPARγ motifs, we uploaded a BED file with their coordinates to the Motif Annotation With Genomic Regions Enrichment of Annotations Tool (GREAT) webportal. 37 Parameters used were Basal+extension 10 000-bp upstream and downstream, 500 000-bp max extension with included curated regulatory domains.
Results
Meta-Analysis of Publically Available PPARγ ChIP-Seq Data Reveals a Large Set of High-Confidence Consensus Peaks
To assess common variation among human PPARγ motifs, it was first necessary to establish a set of consensus genomewide binding sites. As the primary site of expression and action for PPARγ is adipose tissue, we searched the Gene Expression Omnibus-Sequence Read Archive and European Nucleotide Archive databases for ChIP-Seq experiments conducted in mature human adipose cell lines. Our search revealed 4 data sets meeting this criteria. 19, 20, 38, 39 Three studies supplied ChIP-Seq ChIP and input raw Fastq files, and were subsequently used in our analysis ( Table 1) .
Data from these studies were first processed by MACS and analyzed with the meta-analysis software MM-ChIP. The MM-ChIP software enables the integration of ChIP-Seq data sets across different platforms and experiments. 25 This analysis identified 27 328 consensus PPARγ peaks from the pooled ChIP-Seq input. The total number of peaks identified by MM-ChIP and individual studies with false discovery rate values of <0.05 are shown in Table 1 . All peaks called from MM-ChIP and the individual studies are found in Tables I to 4 in the Data Supplement.
MM-ChIP Peaks Are Enriched for Both the Canonical PPARγ:RXR Motif and for Gene Ontology Biological Processes Relating to Lipid Metabolism
Given that each MM-ChIP peak spans hundreds of bases, we next wanted to identify the specific region, or motif, in each peak that PPARγ was likely binding. To determine the most significantly over represented transcription factor motif within our MM-ChIP peaks, we used the MEME-ChIP software. 26 We screened our sequences against the Jaspar 2014 Core vertebrate database in addition to the unique consensus PPARγ motif identified in Lemay et al. 27 The most significant denovo sequence identified by MEME-ChIP is shown in Figure 1A . This denovo motif showed greatest similarity to the DR1 PPARγ:RXR motif MA0065.2, as reported by Tom-Tom (Table V in the Data Supplement; Figure 1A ). Centrimo identified MA0065.2 as the most centrally enriched motif within the sequence set ( Table VI in the Data Supplement). Furthermore, Centrimo showed lesser enrichment for CEBP (β and α). This result provides an additional level of confidence for the identified PPARγ motifs because evidence suggests CEBP binds adjacent to PPARγ to cooperatively initiate adipogenesis. 40 Centrimo also showed enrichment for another nuclear hormone receptor, hepatocyte nuclear fac-tor4, known to have sequence overlap, and competitive binding with PPARγ.
We next mapped the occurrence of MA0065.2 to peaks from each of the individual studies and from MM-ChIP. To account for the uneven number of peaks between studies, we calculated the percentage of PPARγ motifs found per study. Peaks called from MM-ChIP showed a greater percentage of mapped motifs than those from the individual data sets ( Figure 1B) . In total, we identified 8637 PPARγ motifs with a q value of <0.05 in the peaks called by MM-ChIP (Table VII in the Data Supplement).
To determine the potential role of these sequences in cardiometabolic processes, we mapped each motif containing peak to their closest genes using the GREAT webportal and screened these for enrichment of Gene Ontology Biological Processes. 37 The 50 top ranking results show enrichment in processes of lipid and glucose metabolism ( Table VIII in the Data Supplement). GREAT analysis showed a small percentage of PPARγ motifs fall within 5 kb of a known transcription start site, whereas the majority fall at least 50 kb away, which is in-line with what has been reported previously ( Figure 1C ).
A Portion of Human PPARγ-Binding Motifs Show Evidence of Weak Negative Selection
Previous knowledge of PPARγ's involvement in cardiometabolic outcomes makes variation within targets probably candidates for functional impact. However, there has been no assessment of genetic variability within PPARγ motifs among human populations. With 8637 PPARγ motifs identified, we next were interested in characterizing genetic variation within their sequences. With consensus ChIP-Seq peak data with mapped coordinates for likely DR1 motifs, we created a catalog of common variants falling in putative PPARγ PPREs by screening the 8637 PPARγ motifs against dbSNP141. After filtering SNPs on several criteria, we identified 146 PPARγ SNPs for further analysis ( Table IX in the Data Supplement).
If these sequences represent functional PPARγ-binding motifs, we suspected they might be conserved across species, and SNPs within them would likely have functional consequence detectable in association data. Interestingly, several comparative ChIP-Seq studies have demonstrated that although the pathways and individual targets of PPARγ remain conserved, there is a substantial amount of turnover in the determinate sequences between mouse and human. 19, 20 To investigate this in our data, we used the CompleteMOTIFS web tool to obtain the average 46-way phastcons vertebrate conservation scores for each of the 8637 PPARγ-binding motif sequences identified, and compared it to the average phastcons scores from 100 randomly generated sets of 8637 nt sequences. Although the PPARγ motifs show greater conservation than background, our data are in-line with previous reports showing a small percentage, 1310 (15%), of PPARγ motifs are well-conserved across mammals ( Figure 2A ; Table  VII in the Data Supplement). 19, 20 Thus, conservation status among these PPARγ sequences will not necessarily implicate a functional consequence for SNPs mapped to them.
Interestingly, 2 studies investigating nonconserved, noncoding regulatory DNA sequences from ENCODE data showed evidence of reduced human diversity, suggesting lineage-specific purifying selection. 41, 42 To assess whether the PPARγ sequences derived here might be under similar selective pressures, we first determined the likelihood of observing 146 SNPs in our 8637 sequences by chance. To do this, we generated 1000 sets of 8637 random 15 nt sequences from hg19 and assessed them for common variants. From these 1000 simulations, the mean number of SNPs found was 245.48 and the SD was 18.23. The probability of finding 146 or fewer SNPs based on this distribution was calculated to be 2.65×10 −8 , suggesting a significant effect of negative selection.
Several confounding factors that can bias the comparison of variation among sequence sets such as variable mutation rates across loci and coalescence time across the genome were not controlled for in the analysis above. 33 To better assess this putative effect of negative selection on human PPARγ motifs, we submitted our 8637 sequences to the INSIGHT webportal. 33 INSIGHT estimated that a significant (P<0.01) fraction (27%) of the 8637 PPARγ sites are under selection (P; Summary data from 3 PPARγ ChIP-Seq data sets derived from mature human adipocyte cell lines, in addition to results from the meta-analysis performed. The Gene Expression Omnibus Study Accession and SRA numbers are provided. The Model-Based Analysis of ChIP-Seq estimated d and number of mapped reads per study are also provided. Note that although SRX019520 had the most peaks, it was MM-ChIP that was most sensitive and provided the greatest number of motif containing peaks. ChIP-Seq indicates chromatin immunoprecipitation-sequencing; FDR, false discovery rate; hACS, human adipose-derived stem cell; MM-ChIP, Model-based Metaanalysis of ChIP data; PPARγ peroxisome proliferator-activated receptor γ; SGBS, Simpson-Golabi-Behmel syndrome; and SRA, Sequence Read Archive. Figure 2B ). Furthermore, INSIGHT estimated these PPARγ motifs have significantly (P<0.01) elevated rates of negative selection (E[Pw]), with 0.83 SNPs under weak negative selection per kbp ( Figure 2B ).
To achieve better resolution of the specific subsequence under selection, we analyzed the 2 repeated AGGTCA sequences within the mapped PPARγ DR1 consensus motif. As shown in Figure 2C , each repeat was estimated to have a significant (P<0.01) fraction of sites under selection, 36% for first repeat, and 29% for the second repeat. Although each repeat was estimated to have significantly (P<0.01) elevated rates of SNPs under negative selection (first, 0.90; second, 1.18 polymorphisms under negative selection per kbp) the second repeat showed a slightly stronger effect. These results suggest each repeat is constrained and functionally relevant.
Enrichment of Significant PPARγ SNP Associations With Cardiometabolic Traits Found in Published and Unfiltered GWAS Results
We hypothesized that SNPs falling in PPARγ motifs would be candidates for functional relevance and show association with cardiometabolic traits. To ensure we captured all potential association signal we calculated LD for the 146 PPARγ SNPs using the phase 3 CEU 1000 genomes data using a first pass of r 2 of ≥0.9. We performed a second pass of r 2 of ≥0.8 for those SNPs not having a proxy SNPs with r 2 of ≥0.90 (Table X in the Data Supplement). Each SNP was screened against the published GIANT, MAGIC, and Global Lipids GWAS results for the phenotypes of high-density lipoprotein, low-density lipoprotein, triglycerides, body mass index, waist circumference, fasting glucose, and insulin. If the SNP was not available, we used the LD SNP with the greatest number of subjects as a proxy. The number of SNPs available in each cohort, either original or proxy, ranged from 123 to 124 of 146 (≈85%; Table  IX in the Data Supplement). These data sets include unfiltered results from all SNP trait associations performed in the original studies. All GWAS results can be viewed in Table XI in the Data Supplement . Sixteen SNPs reached, at least nominal, significance and are shown in Table 2 . Several SNPs (or their proxies) showed association with multiple anthropometric (rs11075256, rs6718195, and rs6860445), diabetes mellitus-related (rs157507) or blood-lipid (rs4418728) traits. The rs4418728 is in high-LD with a previously identified GWAS SNP rs2068888 associated with modulation of triglycerides for which no functional data exists. 9 We next screened a 50-kb region around each PPARγ SNP to determine if proximal SNPs might also contribute significantly to variability in the associated trait. Eight of 16 SNPs were found to be the highest ranked association SNP (lead), or in high-LD (rs>0.90) with the lead association SNP for the respective cardiometabolic trait (Table 2) . Interestingly, LD between rs11105358 and the proximal lead SNP was <0.01, suggesting independent contributions to variability in triglycerides. Except for rs157507 and rs6860445, the remaining SNPs showed either weak LD with the lead SNP or similar P values to those of the lead SNP. Thus, the data for these last 6 SNPs suggest the contribution to phenotypic variation of the PPARγ SNPs may be shared.
Given that a fraction of the PPARγ motifs are under selection, we asked if the reduced number of variants found within these sites are enriched for significant cardiometabolic associations. To perform the enrichment analyses, we submitted the 124 PPARγ SNPs found in the GWAS data to the SNPSNAP webtool. SNPSNAP controls for confounding factors such as LD, minor allele frequency, distance to nearest gene, and gene density when generating background sets for SNP enrichment analysis. SNPSNAP provided us with 1000 sets of 124 SNPs with similar characteristics as our input. Each set was screened against the GWAS data sets and the number of SNPs having a P<0.01 for any of the traits investigated were tallied. From these 1000 simulations, the mean number of SNPs was 10.51 and SD was 3.16 resulting in a significant enrichment of PPARγ SNPs modulating cardiometabolic traits (P=0.041).
Enrichment of Significant PPARγ eQTL SNPs in Human Subcutaneous Adipose Samples
As this and previous studies have demonstrated a majority of PPARγ motifs are dispersed throughout intergenic regions of the Human Genome. To gain insight into the potential target, loci regulated by these PPARγ motifs we screened the 16 SNPs identified against human subcutaneous adipose tissue eQTL data downloaded from the MuTHER study webportal. 8 After adjustment for multiple testing, we identified 8 SNPs showing eQTL effects with ≥1 loci with q values below 0.2 ( Table 3) .
We next identified the lead eQTL SNP for each locus and determined if they overlapped with our PPARγ SNPs. The proxy SNP for rs756145 was the lead eQTL for DMRT2 ( Table 3 ). The rs11105358 SNP showed weak LD for the lead GALNT4 eQTL SNP (r 2 =0.13). However, because of the drastic difference in P values the contribution of rs11105358 to expression of GALNT4 will require conditional analysis and further functional experiments to determine its functional potential as a modulator of GALNT4 expression. Five additional eQTLs showed an r 2 value of <0.10 with lead SNP and, therefore, may be independently contributing to the expression of their linked genes. The remaining 3 eQTL SNPs showed weak to moderate LD (r 2 >0.20) with lead eQTL SNPs. Therefore, the contribution of these SNPs to expression at these loci should be interpreted with caution.
Given that these SNPs are presumably linked to functional consequence, we next determined if they represented an enrichment of eQTL SNPs. To do this, we used SNAPSNP and generated 1000 sets of 16 matched SNPs and screened them against the eQTL data. We tallied the number of SNPs having a q value of <0.2 for each set. The mean number of SNPs was 3.22 and SD was 2.57. On the basis of this distribution, the likelihood of observing 8 eQTL SNPs with a q value of <0.2 was P=0.032. The change in sequence for each SNP on the predicted motif can be viewed in Figure I in the Data Supplement. eQTL data for the 16 SNPs can be viewed in Table XII in the Data Supplement.
Discussion
Here, we have integrated experimental data on PPARγ binding and eQTL data from adipose cell lines with published GWAS results and identified 8 potential functional SNPs affecting cardiometabolic outcomes. Our meta-analysis of PPARγ ChIP-Seq data identified 27 328 consensus peaks across the human genome. Furthermore, the most enriched sequence identified from these 27 328 sequences showed greatest similarity to MA0065.2, the canonical PPARγ:RXR DR1 motif, which we subsequently mapped, with high confidence, to 8637 peaks.
We recognize that this represents only a third of the total number of PPARγ peaks discovered. However, we chose to include only high-confidence motifs at the expense of false negatives. For example, if we had selected a q value threshold of <0.10 our MM-ChIP PPARγ:RXR motif count would jump from 8637 to 14 696. Other important factors reducing the number of mapped motifs relates to both sequence and epigenomic context. Several studies have demonstrated an effect of flanking sequence context on PPARγ-binding affinity. 43, 44 It is also plausible that other novel motifs, unique from the DR1, may be responsible for binding a subset of PPARγ peaks. 27 Furthermore, transcriptional coactivators may be acting in concert with weaker variants of the DR1 motif, not identified in our screen, to initiate transcriptional activity.
Our observation of poor conservation in PPARγ motif sequences agrees with previous studies showing a majority of sites are weakly conserved between mouse and human. 19, 20 These data suggest an elevated rate of evolutionary turnover among PPARγ regulatory elements. Furthermore, our INSIGHT analysis showed an increase of SNPs under weak negative selection in the identified PPARγ motifs compared with neutrally evolving flanking sequences. Weak negative selection is thought to allow for variation but prevent deleterious-derived alleles from reaching high frequencies.
Taken together it seems that the PPARγ motifs identified have undergone significant evolutionary turnover followed by lineagespecific constraint in humans. A similar pattern of divergence and polymorphism among motifs has been observed for other transcription factor-binding sites in the human genome, thus emphasizing the importance of noncoding and nonconserved DNA elements in the evolutionary adaptation of regulatory sequences. 41, 45 We speculate that the observed turnover and constraint in PPARγ motifs were important for adaptation of the thrifty genome in early humans in response to available dietary factors. 46 Heinäniemi et al 47 observed that, across species, many PPARγ targets harbor a series of putative PPREs and that any one of them may be functional at any time. 47 So, it is hypothesized that the loci under PPARγ control remain conserved by buffering their response with a series of potential functional motifs. The overlap of bound targets but lack of conservation between PPARγ ChIP-Seq peak sequences of human and mouse adipocytes supports this idea. 19, 20 Furthermore, we hypothesize that the observed fraction of human PPARγ sites showing sequence constraint is evidence of their regulatory activity. The A1 column indicates the effect allele, n the number of subjects, and phastcons the conservation score. The β and SE describe the size and direction of the allelic effect. Lead SNP, P, and r 2 indicate the SNP with the most significant association within the surrounding 50 kb of the PPARγ SNP, the P value for the lead SNP and the r 2 value between the lead SNP and the PPARγ SNP, respectively. Dashes (-) in the proxy column indicate the PPARγ SNP was found in the GWAS data set, otherwise the proxy SNP was used. Dashes (-) in the lead SNP and lead P columns indicate the PPARγ SNP is the lead SNP or in high-linkage disequilibrium (r 2 >0.90) with the lead SNP. Triglycerides in mg/dL (TG), low-density lipoprotein (LDL) cholesterol in mg/dL, high-density lipoprotein (HDL) cholesterol in mg/dL, body mass index (BMI) in kg/m 2 , waist in cm (waist circumference), glucose in mmol/L (fasting glucose), and insulin in logged mmol/L (fasting insulin). GWAS indicates genome-wide association studies; PPARγ, peroxisome proliferator-activated receptor γ; SNP, single nucleotide polymorphism; and TG, triglycerides.
Given the result that a fraction of the identified PPARγ sequence motifs are under weak negative selection, we hypothesized SNPs falling in these motifs would have greater potential for functionality and, therefore, may be enriched for association signal with ≥1 cardiometabolic traits. Our finding of significant enrichment (P=0.041) suggests this is the case. Further supporting the functionality of the 16 SNPs identified, we showed an enrichment of 8 of these SNPs for significant allelic expression differences in human adipose. It should be noted that only 1 of these SNPs, rs756145, seems to be the lead eQTL for the respective loci, and can therefore be considered a true functional candidate (Table 3 ). Future work, including conditional analysis for these candidate SNPs with the lead eQTL SNP will help to determine their true contribution to gene expression. Alternatively, these PPARγ SNPs may fall nearby lead eQTLs that alter expression of genes related to metabolic outcomes.
In this report, we show that the minor allele of rs4418728 is predicted to strengthen the binding of PPARγ to a PPRE 2-kb upstream of the CYP26A1 locus ( Figure I in the Data Supplement). Furthermore, the rs4418728 minor allele is in high-LD with rs2068888, an SNP showing GWAS significance with several blood-lipid traits. CYP26A1 is a member of the cytochrome P450 superfamily of enzymes and is thought to be essential for maintenance of retinoic acid (RA) homeostasis, mainly through RA catabolism. RAs are important factors in maintaining body weight and glucose homeostasis. However, administration of RA compounds in both animal models and human subjects has demonstrated paradoxical results, particularly with blood lipids. 48 Given the binding promiscuity of RXR receptors, the effects of RA may differ depending on concentrations of particular binding partners (LXRs, PPARs, etc) in any 1 tissue at any point in time. If the PPARγ motif identified here differentially regulates RA catabolism between genotypes, it may explain, in part, the inconsistencies observed in lipid metabolism in response to RA. Thus, the role of this PPARγ motif with regard to the effects of RA signaling warrants experimental follow-up.
Another, more tenuous, SNP of interest is rs11105358 where the minor allele associated with lower triglycerides levels in addition to a putative increase in the expression level of the cardiovascular disease candidate gene GALNT4. Previous studies have demonstrated a significant association with increased coronary artery disease risk with the GALNT4 SNP rs7136259. 49 In 2 additional studies, the rs7136259 risk allele was associated with reduced GALNT4 expression in monocytes. 50, 51 GALNT4 encodes an N-acetyl galactosaminyl transferase 4 enzyme thought to play an important role in endothelial-platelet interactions by O-glycosylating the threonine residues of the P-selectin glycoprotein ligand (PSGL-1). Interestingly, the minor C allele of rs11105358 better matches the PPARγ::RXR consensus motif suggesting increased expression through greater affinity for PPARγ ( Figure I in the Data Supplement). Although the activity of GALNT4 and PSGL-1 are not well characterized in adipose tissue, we hypothesize an important role for them in protein glycosylation, including P-selectin, and subsequent effects on lipid trafficking. This hypothesis should be viewed with caution, until a functional experiment is conducted or a conditional analysis is able to determine if the effect of rs11105358 on GALNT4 expression is independent from the highly significant lead SNP rs9308287.
Our data show that a functional genomics approach can overcome the burden imposed by GWAS of statistical stringency by identifying a subset of SNPs with functional hypotheses. PPARγ is known as a lipid sensor and is an important factor for proper metabolic response to dietary stimuli. However, identifying if and how these SNPs may modulate this response remains a challenge considering the large number of subjects often required to detect gene by diet interactions combined with the heterogeneity in dietary factors across study samples. Although this article was under review, an article by Soccio et al 52 was published detailing the significant effect of genetic variation in PPARγ motifs among different mouse strains on gene expression in response to antidiabetic drugs. They extended their analysis to human fat samples and discovered a modest enrichment for PPARγ SNPs in eQTL data and GWAS hits for lipid traits. Although Soccio et al 52 used a model organism approach to demonstrate The A1 column indicates the effect allele, whereas the β and SE indicate the relative change in expression. Dashes (-) in the proxy column indicate the PPARγ SNP was found in the eQTL data set, otherwise the proxy SNP was used. Lead SNP, P and r 2 indicate the SNP with the most significant eQTL association for the gene, the P value for the lead SNP and the r 2 value between the lead SNP and the PPARγ SNP, respectively. Dashes (-) in the lead SNP and lead P columns indicate the PPARγ SNP is the lead SNP or in high-linkage disequilibrium (r 2 >0.90) with the lead SNP. MuTHER indicates Multiple Tissue Human Expression Resource; PPARγ, peroxisome proliferator-activated receptor γ; and SNP, single nucleotide polymorphism.
proof of concept for the modulation of lipid traits by genetic variation in PPARγ motifs, our analyses relied strictly on computational approaches. Furthermore, although Soccio et al 52 also discovered an enrichment of SNPs with cardiometabolic associations in GWAS and for eQTL hits the data sets interrogated differed between studies. These studies demonstrate complementary functional genomic approaches used to uncover SNPs of metabolic and functional impact.
Although we have successfully identified many candidate functional SNPs, our methodology is not without pitfalls. PPARγ is a master regulator responsive to multiple environmental stimuli. Therefore, with the ChIP-Seq method we are likely capturing only a fraction of the targets bound by such a dynamic regulator. In addition, we found 85% of our 146 SNPs in published GWAS datasets, leaving ≈20 SNPs uncharacterized. We did not investigate more rare SNPs in this analysis, thus additional SNPs of low frequency are likely. Nonetheless, we were able to identify a subset of SNPs that significantly modulate cardiometabolic outcomes. Future analysis of these SNPs will focus on the investigation of their effects of interaction with dietary and pharmaceutical compounds on cardiometabolic outcomes. In addition, experimental validation will be important for several SNPs where the direction of the expression effect is difficult to predict based on the nucleotide composition of particular sites within the MA0065.2 positional weight matrix (rs12500887, rs157507, and rs77755737).
In conclusion, we demonstrate the use of functional genomics by interrogating Big Data to inform selection of candidate SNPs for functional consequence. Our data indicate that common variation in human PPARγ motifs is rare, but enriched for significant association with cardiometabolic traits and gene expression. Experimental validation of these motifs will clarify the impact of these SNPs on gene expression and subsequent consequences on cardiometabolic outcomes.
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